MedPath

Retrospective analysis of safety and effectiveness of recombinant thrombomodulin for vascular endothelial syndrome after hematopoietic cell transplantation in children.

Not Applicable
Recruiting
Conditions
Pediatric patients who developed vascular endothelial syndrome after hematopoietc cell transplantation.
Registration Number
JPRN-UMIN000022640
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who did not meet the inclusion criteria. Patients who disagreed to write the consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath